Markus Grube
- Oncology top 1%
- Drug Transport and Resistance Mechanisms 48
-
- Pharmacological Effects and Toxicity Studies 20
- Pharmacology top 1%
- Pharmacogenetics and Drug Metabolism 6
- Antibiotics Pharmacokinetics and Efficacy 6
- Clinical Biochemistry top 2%
- Metabolism and Genetic Disorders 8
- Biochemistry top 2%
- Amino Acid Enzymes and Metabolism 4
-
- Trace Elements in Health 9
-
- Pregnancy and Medication Impact 6
- Co-authors
- Heyo K. KroemerGabriele JedlitschkyHenriette E. Meyer zu SchwabedissenWerner SiegmundKathleen KöckChristoph A. RitterStefan OswaldSilke Vogelgesang
- Journals
- Drug Metabolism and Disposition (8 papers)Naunyn-Schmiedeberg s Archives of Pharmacology (3 papers)Molecular Pharmaceutics (3 papers)
- Partner nations
- GermanySwitzerlandUnited States
In The Last Decade
Markus Grube
71 papers receiving 3.3k citations
Peers
Comparison fields: 5 of 125
- Oncology 1.7k
- Pediatrics, Perinatology and Child Health 810
- Pharmacology 277
- Clinical Biochemistry 192
- Biochemistry 189
Countries citing papers authored by Markus Grube
This map shows the geographic impact of Markus Grube's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Grube with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Grube more than expected).
Fields of papers citing papers by Markus Grube
This network shows the impact of papers produced by Markus Grube. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Grube. The network helps show where Markus Grube may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Markus Grube, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 6 | |
| 2 | 2021 | 10 | |
| 3 | 2019 | 44 | |
| 4 | 2017 | 49 | |
| 5 | 2016 | 16 | |
| 6 | 2016 | 21 | |
| 7 | 2015 | 25 | |
| 8 | 2011 | 18 | |
| 9 | 2011 | 63 | |
| 10 | 2011 | 34 | |
| 11 | 2010 | 53 | |
| 12 | 2010 | 74 | |
| 13 | 2009 | 52 | |
| 14 | 2007 | 15 | |
| 15 | 2007 | 191 | |
| 16 | 2006 | 28 | |
| 17 | 2006 | 51 | |
| 18 | 2004 | 146 | |
| 19 | 2004 | 5 | |
| 20 | 2002 | 20 |
About Markus Grube
Markus Grube is a scholar working on Oncology, Clinical Biochemistry and Pediatrics, Perinatology and Child Health, having authored 71 papers that have together received 3.3k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (48 papers), Pharmacological Effects and Toxicity Studies (20 papers), Trace Elements in Health (9 papers), Metabolism and Genetic Disorders (8 papers), Pharmacogenetics and Drug Metabolism (6 papers), Pregnancy and Medication Impact (6 papers), Antibiotics Pharmacokinetics and Efficacy (6 papers) and Amino Acid Enzymes and Metabolism (4 papers). The work is most often cited by research in Oncology (1.7k citations), Pediatrics, Perinatology and Child Health (810 citations) and Pharmacology (277 citations). Markus Grube has collaborated with scholars based in Germany, Switzerland and United States. Frequent co-authors include Heyo K. Kroemer, Gabriele Jedlitschky, Henriette E. Meyer zu Schwabedissen, Werner Siegmund, Kathleen Köck, Christoph A. Ritter, Stefan Oswald, Silke Vogelgesang, Christoph Fusch and Markus Keiser. Their work appears in journals such as Drug Metabolism and Disposition, Naunyn-Schmiedeberg s Archives of Pharmacology, Molecular Pharmaceutics, Biochemical Pharmacology and Journal of Pharmaceutical Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.